ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $131,000 | -98.2% | 48,821 | -94.6% | 0.00% | -100.0% |
| Q3 2016 | $7,360,000 | +8.4% | 908,673 | +4.4% | 0.01% | 0.0% |
| Q2 2016 | $6,788,000 | +8.3% | 870,293 | +7.2% | 0.01% | +14.3% |
| Q1 2016 | $6,267,000 | -13.2% | 811,772 | +21.4% | 0.01% | -12.5% |
| Q4 2015 | $7,218,000 | +861.1% | 668,918 | +634.0% | 0.01% | +700.0% |
| Q2 2013 | $751,000 | – | 91,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |